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ABSTRACT
Diabetes mellitus is a multisystemic disease characterized by hyperglycemia due to defects in
insulin secretion and action, or both. Hyperglycemia is the most important factor in the onset
and progress of diabetic complications. Hyperglycemia increases the expression of receptor for
advanced glycosylation end products (RAGE) which leads to pancreatic -cells damage. Yellow
soybean (Glycine max) is reported to contain isoflavones which have various biological properties
including antidiabetes. Dietary soybean can prevent the progression of diabetic complications.
This study was conducted to investigate the effects of yellow soybean powder suspension on
expression of RAGE and pancreatic -cells damage of diabetic rats. Thirty streptozotocin (STZ)-
induced diabetic Sprague Dawley male rats aged 11-12 weeks with body weight 200-250 g were
used in this study. The rats were divided into 5 groups with 6 rats in each group. Group 1 was
non diabetic rats. Group 2 was diabetic rats without treatment. Group 3-5 were given yellow
soybean powder suspension of 400, 800 and 1600 mg/kg BW for four weeks, respectively. At
the end of the experiment, pancreases tissues were removed for examination of RAGE expression
and pancreatic -cells. The results showed that yellow soybean powder suspension ingestion
signifantly decreased blood glucose level of diabetic rats toward normality (p<0.05). Moreover,
the percentage of RAGE expression on Group 3 (50.01±2.75%) and Group 2 (53.03±4.02%)
were not significantly different (p>0.05). Meanwhile, the percentage of RAGE expression on
Group 4 (42.43±4.08%) and Group 5 (40.62±3.42%) were significantly lower than Group 2
(p<0.05). The percentage of pancreatic -cells on Group 2 (10.04±1.56%) was not significantly
different compared to Group 3 (8.61±0.81%) (p>0.05), whereas the percentage of pancreatic
-cells in Group 4 (16.78±7.79%) and in Group 5 (22.03±11.51%) were significantly higher
than Group 2 (p<0.05). In conclusion, yellow soybean powder suspension can decrease RAGE
expression and prevent pancreatic -cells damage on STZ-induced diabetic rats.
ABSTRAK
Diabetes melitus adalah penyakit multisistemik ditandai dengan hiperglikemia akibat kerusakan
sekresi dan atau aksi insulin. Hiperglikemia merupakan faktor paling penting bagi timbulnya dan
perkembangan komplikasi diabetes. Hiperglikemia dapat meningkatkan ekspresi receptor for
advanced glycosylation end products (RAGE) dan menyebabkan kerusakan selpankreas. Kedelai
kuning (Glycine max) dilaporkan mengandung isoflavon yang mempunyai berbagai aktivitas biologis
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termasuk antidiabetes. Diet kedelai dapat mencegah perkembangan komplikasi diabetes. Penelitian
ini dilakukan untuk mengkaji efek suspensi bubuk kedelai kuning terhadap ekspresi RAGE dan
kerusakan sel-pankreas tikus diabetes. Tigapuluh tikus jantan Sprague Dawley diabetes yang
diinduksi streptosotosin (STZ) berumur 11-12 minggu dengan berat 200-250 g digunakan dalam
penelitian ini. Tikus dibagi 5 kelompok, masing-masing kelompok 6 tikus. Kelompok 1 adalah
tikus normal. Kelompok 2 adalah tikus diabetes tanpa perlakuan. Kelompok 3-5 adalah tikus
diabetes diberi suspensi bubuk kedelai kuning berturu-turut dosis 400, 800 dan 1600 mg/kg BB
selama 4 minggu. Di akhir penelitian, jaringan pankreas diambil untuk pemeriksaan RAGE dan sel
pankreas. Hasil penelitian menunjukkan bahwa pemberian suspensi bubuk kedelai kuning
menurunkan secara nyata kadar gula darah tikus diabetes hingga normal (p<0,05). Selain itu,
persentase ekspresi RAGE Kelompok 3 (50,01±2,75%) dengan Kelompok 2 (53,03±4,02%)
tidak berbeda nyata (p>0,05). Sedangkan, persentase ekspresi RAGE Kelompok 4 (42,43±4,08%)
dan Kelompok 5 (40,62±3,42%) lebih rendah secara nyata dengan Group 2 (p<0,05). Persentase
sel pankreas Kelompok 2 (10,04±1,56%) dengan Kelompok 3 (8,61±0,81%) tidak berbeda
nyata (p>0,05). Sedangkan persentase selpankreas Kelompok 4 (16,78±7,79%) dan Kelompok
5 (22,03±11,51%) lebih tinggi secara nyata dari Kelompok 2 (p<0,05). Dapat disimpulkan,
suspensi bubuk kedelai kuning dapat menurunkan ekspresi RAGE dan mencegah kerusakan sel-
pankreas pada tikus diabetes yang diinduksi STZ.
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INTRODUCTION
Diabetes mellitus (DM) is a multi-systemic
disease characterized by hyperglycemia as the
result of defects in insulin secretion, action, or
both.1 The prevalence of diabetes worldwide
was estimated to be 2.8% in 2000 and 4.4% in
2030. The total number of people with diabetes
was projected to rise from 171 million in 2000
to 366 million in 2030. In Indonesia, the people
with DM reached 8.4 million in 2000 and it
will be 21.3 million in 2030. Indonesia is the
fourth country with the highest people with
diabetes in the world after India, China dan
USA.2
Hyperglycemia is the most important factor
in the onset and progress of diabetic
complications. Hyperglycemia is generally
accepted to be the major cause of diabetic
microvascular complications including
nephropathy, neuropathy and vision disorders
such as retinopathy, glaucoma, cataract and
corneal disease. Moreover, hyperglycemia also
plays an important role in the development of
macrovascular diseases including cardio-
vascular disease, stroke and peripheral vascular
disease which can lead to ulcers, gangrene and
amputation.3,4
Hyperglycemia causes cells oxidative
damage by generation of reactive oxygen
species (ROS) produced mainly through the
glycation reaction resulting in advanced
glycosylation end products (AGEs), a non-
enzymatic reaction product of glucose.5
Advanced glycosylation end products have been
implicated in an increasing number of diabetic
complications that result from, and in, oxidative
damage due to ROS generation.6,7 Advanced
glycosylation end products are capable of
damaging DNA either directly or by the
generation of ROS through the activation of
receptor for AGEs (RAGE).7,8 Advanced
glycosylation end products may directly
influence the structural integrity of the vessel
wall and underlying basement membranes
through excessive cross linking of matrix
molecules such as collagen and disruption of
matrix-matrix and matrix-cell interactions.9,10 In
addition, binding of AGEs to RAGE in many
cell types provokes a range of pathophysio-
logical responses linked to the downstream
activation of NFkB and other signalling
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pathways that lead to ROS generation and
certain pro inflammatory responses.11,12
Prevention and regeneration of further
pancreatic-cells damage are important in the
management of DM to prevent its complications.
The management of DM is a long term treatment
to control hyperglycemia and hypoinsulinemia.
The development and application of natural
product are expected to control hyperglycemia,
prevent pancreatic -cells damage, repair
insulin synthesis and secretion, and improve
insulin resistance. Several studies have been
conducted to evalute effect of natural products
to treat DM in animal model including black
cumin (Nigella sativa),13,14 cinnamon (Cinna-
momum zeylanicum),15 mahogany (Swietenia
mahagoni),16 and soybean (Glycine max).17
Glycine max or yellow soybean, locally
known as kedelai kuning, is one of legumes
used empirically to prevent and treat diseases
associated with DM. Elevated intake of soybean
legumes has been linked to a decreased risk of
glucose intolerance18 and type 2 diabetes.19,20
Soyabean is reported to contain isoflavones
which have various biological properties
including antidiabetes. Dietary soy isoflavones
increase insulin secretion and prevent the
development of diabetic cataracts in diabetic
rats.21 Moreover, dietary soybean can prevent
the progression of diabetic rats and therefore
neprhopathy can be prevented.22 The objective
of this study was to investigate the effects of a
yellow soybean powder suspension ingestion
on RAGE expression and on pancreatic-cells
damage of streptozotocin (STZ)-induced
diabetic rats.
MATERIALS AND METHODS
Preparation of the yellow soybean powder
suspention
Yellow soybeans were purchased from a
local market in Yogyakarta District. Soybean
seeds were washed with water and dried in an
oven at 60oC for 30 minutes. Dried soybean
seeds were then powdered with a blender.
Soybean powder suspentions were then
prepared in two mL water of each dose. Three
different doses of suspentions were prepared
for each rat group i.e. 400, 800 and 1600 mg/kg
BW for this study.
Animals and induction of diabetes
Thirty male Sprague Dawley rats (Rattus
novergicus) aged 11-12 weeks with body weight
200-250 g obtained from the Integrated Research
and Testing Laboratory, Universitas Gadjah
Mada, Yogyakarta were used in this study. The
rats were housed at room temperature under 12
hour cycles of dark and light, were fed a
standard food and provided an access to water
ad libitum. After an acclimatization period of
one week, rats were divided into 5 groups with
6 rats in each group. Group 1 as normal contol
was non diabetic rats. Group 2 as negative
control was diabetic rats without treatment.
Group 3-5 as treatment groups were given
yellow soybean powder suspension of 400, 800
and 1600 mg/kg BW for each group,
respectively.
Diabetic rats were induced by a single
intraperitoneal injection of STZ at dose 60 mg/
kg BW in 0.01 M at pH 4.5. Blood samples
were collected from orbital sinus and blood
glucose level was determined by using GOD
PAP method before (day 0) and three days after
STZ induction (day 3). Diabetic rats were
confirmed if blood glucose level was >200 mg/
dL. Two weeks after diabetic rats were
confirmed, yellow soybean powder suspension
were then ingested for four weeks.
Rats were sacrified four weeks after the
suspension ingestion and after blood glucose
level determination (day 52). The rats were
anesthetized using diethyl ether. A transverse
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abdominal incision was made and pancreases
and deudenom were removed from the rat. The
pancreases tissues were then divided into two
parts, the first part for immunohistochemical
analysis of RAGE expression and the second
part for histological examination of pancreatic
-cells. Fixed pancreases tissues were
processed routinely for paraffin embedding.
Serial sections of 5 ìm for each pancreas tissue
sample were cut and placed on a poly L-lysine
coated glass microscope slide.
Immunohistochemical analysis of RAGE
expression
The pancreas tissue sections were
deparaffinized, rehydrated using a sequence of
xylene, graded ethanol, water then washed in
PBS. Briefly, antigen unmasking was performed
by incubating the sentions with a 50% trypsin :
50% vercene solution for 2 minutes.After being
washed in water for 20 minutes, the sections
were permeabilized in 0.1% Triton X-100 for
20 minutes, and rinsed in PBS (phosphate
buffered saline solution). The sections were then
blocked with endogenous peroxidase by
incubating the slides with a 3% H2O2 : 0.01%
avidin for 5 minutes and washed in water. The
next day, the sections were washed again in PBS
and then incubated with primary monoclonal
antibody anti-mouse RAGE (25 µg/mL)
overnight at 4oC. Following the incubation, the
sections were washed in PBS and then incubat-
ed with a biotinylated secondary antibody for
30 minutes and washed again in PBS. The
sections were incubated with a streptavidine
peoxidase for 30 minutes at room temperature,
washed in PBS and incubated with diamino-
benzidine for 5-10 minutes. The sections were
then lightly countersatined by haematoxylin,
incubated for 30 second at room temperature
and washed in water. The sections were then
dried and coverslipped.
All sections were then examined and
evaluated using light microscope. The RAGE
expression in pancreatic-cells of Langerhans
islets was identified by a brown color of the
cell, while a blue color of a cell indicated no
expression of the RAGE. The RAGE expression
was observed on five Langerhans islets and
percentage of the RAGE expression was
calculated using Cemek 23 formula after
modification as follows:
Histological examination of pancreatic-
cells
The pancreas tissue sections were deparaf-
finized and incubated with a mordant solution
overnight at 37oC. The sections were rinsed in
water and treated with an acidified potassium
permanganate solution for 3 minutes.After being
washed again in water, the sections were treated
with 2-5% sodium bisulphite for 1 minute,
washed well in water and in 70% alcohol. The
sections were then stained with the Victoria Blue
solution for 15 minutes at room temperature,
washed in water and differentiated with 70%
alcohol. The sections were then washed in
running tap water fo 1 minute, dehydrated with
30% alcohol, cleared with xylol solution I, II
and III and coverslipped.
All sections were then examined and
evaluated using light microscope. The existence
of pancreatic-cells in Langerhans islets was
demonstrated by blue cells. The existence of
pancreatic -cells was observed on five
Langerhans islets and its percentage was
calculated using Cemek 23 formula after
modification as follows:
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Statistical analysis
Data were presented as mean ± standard
deviation (SD) and analyzed using SPSS. The
difference between blood glucose levels, RAGE
expression in Langerhans islets and pancreatic
â cell numbers between treatment groups with
control groups were analyzed using Kruskal-
Wallis test. The significant differences between
groups were analyzed with Mann-Whitney test.
A p value <0.05 was accepted as statistically
significant.
RESULTS
Blood glucose level of normal (Group 1),
diabetic (Group 2), yellow soybean powder
suspension diabetic (Group 3-5) groups on day
0, 3, and 52 after STZ induction are shown in
TABLE 1. Before STZ injection (day 0), the
blood glucose level of rats in all groups were
in normal level. However, three days after STZ
induction (day 3) rats in all groups had blood
glucose level higher than 200 mg/dL indicating
that rats were diabetic. Yellow soybean powder
suspension ingestion for four weeks (Group 3-
5) signifantly decreased the blood glucose level
of diabetic rats toward normality (< 200mg/dL)
(p<0.05), whereas the blood glucose level of
diabetic rats (Group 2) did not significantly
decrease on day 52 after STZ injection (p>0.05).
TABLE 1. Blood glucose level of normal, diabetic, yellow soybean powder suspension rat groups on day 0, 3,
and 52 after STZ induction
An example of RAGE expression in
Langerhans islets from normal rats (Group 1),
diabetic rats without treatment (Group 2), and
diabetic rats after ingestion of yellow soybean
powder suspension (Group 3-5) is shown in
FIGURE 1. The positive RAGE expression was
identified by a brown color of the cell (arrow
heads). Mean percentage of RAGE expression
in Langerhans islets from each group is
presented in FIGURE 2. The lowest of RAGE
expression was observed in Group 1 (5.71±
1.45%), while the highest was observed in
Group 2 (53.03±4.02%). The mean percentage
of the RAGE expression in Group 3
(50.01±2.75%) was lower than Group 2,
however it was not significantly different
(p>0.05), whereas, the mean percentage of the
RAGE expression in Group 4 (42.43±4.08%)
and Group 5 (40.62±3.42%) were significantly
lower than Group 2 (p<0.05). No significant
difference in the mean percentage of the RAGE
expression between Group 4 and Group 5 was
observed in this study.
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FIGURE 1. RAGE expression in Langerhans islets in normal rats (Group 1), diabetic rats without
treatment (Group 2), and diabetic rats after ingestion of yellow soybean powder suspension
(Group 3-5). Positive expression (arrow heads) is shown by brown staining. Magnification
of 270x
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FIGURE 2. Percentage of RAGE expression in Langerhans islets in normal and
diabetic rats without and after ingestion of yellow soybean powder
suspension
An example of histology of pancreatic-
cells in Langerhans islets after Victoria Blue
staining in normal rats (Group 1), diabetic rats
without treatment (Group 2), and diabetic rats
after ingestion of yellow soybean powder
suspension (Group 3-5) is shown in FIGURE
3. Positive-cells (arrow heads) is shown by
blue staining. The highest of mean percentage
of pancreatic-cells was observed in Group 1
(40.21±8.68%), while the lowest was observed
in Group 3 (8.61±0.81%). However, it was not
significantly different compared to Group 2
(10.04±1.56%) as control diabetic rats without
ingestion of yellow soybean powder suspension
(p>0.05). Meanwhile, the mean percentage of
pancreatic-cells in Group 4 (16.78±7.79%)
and in Group 5 (22.03±11.51%) were
significantly higher than Group 2 (p<0.05). No
significant difference in mean percentage of
pancreatic-cells between Group 4 and 5 was
observed in this study.
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FIGURE 3. Histology of pancreatic -cells in Langerhans islets after Victoria Blue
staining in normal rats (Group 1), diabetic rats without treatment (Group
2), and diabetic rats after ingestion of yellow soybean powder suspension
(Group 3-5). Posistive -cells (arrow heads) is shown by blue staining.
Magnification of 540x
FIGURE 4. Pancreatic-cells observed in Langerhans islets in normal and
diabetic rats without and after ingestion of yellow soybean
powder suspension
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DISCUSSION
In this study, it was shown that yellow
soybean powder suspension ingestion at dose
of 800 and 1600 mg/kg BW for four weeks
significantly decreased the expression of RAGE
in pancreatic -cells of STZ-induced diabetic
rats. Moreover, this suspension can prevent the
â-cells damage due to STZ-induction. The effect
of this suspension on inhibition of RAGE
expression and prevention of -cells damage
can improve glycemic control as demonstrated
with the decrease of blood glucose level of the
diabetic rats.
The effect of yellow soybean on glycemic
control both in animal model and human has
been reported by some authors. Zimmermann
et al.24 reported that consumptions of soybean
can improve glucose heomeostasis and prevent
the progression of diabetes in the db/db mice.
Choi et al.25 also reported that soybean may
improve glycemic control and prevent the
progression of diabetic nephropathy in rats. A
soybean diet may prevent the weight loss and
morphological disruption of the kidney
associated with diabetes in rats. In addition, Xu
et al.26 suggested that soybean fibers can control
blood glucose level, blood-lipid level by
improving their metabolisms. Therefore, it can
protect liver and renal damage of diabetic mice.
Soybean is reported to contain rich isofla-
vones which are well known as antioxidant with
various biological properties including
antidiabetes. Glyceollins, soy isoflavone
phytoalexins, improve oral glucose disposal in
prediabetic rats by increasing both the insulin-
mediated and the basal, insulin-independent,
glucose uptake by adipocytes.27 Biochanin A,
another soy isoflavone, showed antihyper-
glycemic effect on STZ-diabetic rats by
decreasing activities of gluconeogenic enzymes
such as glucose 6-phosphatase and fructose 1,6-
biphosphatase and by increasing glucokinase,
glucose 6-phosphate dehydro-genase.28
Possible mechanisms underlying the effect
of the yellow soybean on inhibition of RAGE
expression and preservation of pancreatic -
cell damage are thought through antioxidant
activities of soy isoflavones. Hyperglycemia
causes the pancreatic-cells oxidative damage
by generation of ROS produced either directly
or through the glycation reaction resulting in
advanced glycosylation end products (AGEs).
Moreover, AGEs are capable of damaging the
pancreatic -cells either directly or by the
generation of ROS through the activation of
RAGE.7,8 As antioxidant, soy isoflavones can
neutralize ROS produced under hyperglycemic
conditions and maintain the integrity of cell
membranes, and therefore prevent the pancreatic
-cells oxidative damage.29
CONCLUSION
In conclusion, yellow soybean powder
suspension ingestion for four weeks can
significantly decrease the expression of RAGE
of pancreatic-cells on STZ-induction diabetic
rats. Moreover, yellow soybean powder
suspension can prevent the pancreatic-cells
damage due to STZ-induction.
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